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Previously reported studies' have described the isolation methods and initial 
characterization of mycoplasma from patients with rheumatoid arthritis (RA) , 
systemic lupus erythematosus (SLE) , and Reiter's syndrome. These strains were 
isolated in cell culture using two primary cell lines, green monkey kidney and 
diploid human embryonic lung fibroblasts. Inocula included synovial fluid, kidney 
tissue, serum, and bone marrow. All control tubes, and those inoculated with 
material from patients with osteoarthritis, traumatic arthritis, and gout remained 
free of mycoplasma. Growth of mycoplasma in cell-free medium occurred after 
three to eight passages in cell culture. 
TABLE 1 summarizes the number of isolations and cell lines used. Not all speci- 
mens were inoculated into each cell line. In one case, mycoplasma were isolated 
from the same specimen in both cell lines. Mycoplasma have been isolated from 
10 patients with RA, four from SLE, and two from Reiter's syndrome. This 
represents an approximate recovery rate of 20 % . 
Initial studies of antibiotic sensitivity to the RA-SLE strains showed that they 
were relatively resistant to streptomycin and sensitive to tetracycline. However, 
sensitivity to chloramphenicol and kanamycin varied considerably. They fer- 
mented glucose and caused an alpha type hemolysis of sheep red cells. 
The present report describes the antigenic characterization of these strains using 
growth-inhibition, complement-fixation, and gel diffusion methods. A study of 
complement-fixing antibody in serum and synovial fluid from patients with RA 
is included. 
Materials and Methods 
Media. The medium used for isolation and propagation of the organisms was 
similar to that described by Taylor-Robinson et aL2 The six strains of mycoplasma 
studied in detail were each cloned twice3 and subcultured four times in medium 
containing rabbit serum, instead of horse serum, before growing antigens for 
rabbit immunization. 
Production of Rabbit Antisera. Antisera to the mycoplasma strains were pre- 
pared as described in detail previously.' Immunizing antigen represented a 20-fold 
concentration of washed organisms of six-day flask cultures. Complete Freund's 
adjuvant was used to enhance antibody production, and multiple intradermal and 
subcutaneous sites were inoculated. Control rabbits received complete medium 
with adjuvant processed in the same manner as the organisms. 
Complement-fixation Tests. Antigens were grown in standard PPLO medium, 
washed three times and concentrated 20-fold by centrifugation as previously 
described.' The one-fifth volume Kolmer complement-fixation test was used.4 
Antigen was titrated by the block technique, and one unit of antigen was used. 
* This work was supported in part by a grant from the National Institutes of Allergy and 
Infectious Diseases, U.S. Public Health Services. 
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TABLE 1 













synovial fluid 2 
Green monkey kidney. 
t Human embryonic lung. 
This usually represented the most concentrated dilution which was not anticom- 
plementary. Phenol was routinely added to the growing cultures on day five as 
described by C h a n o ~ k . ~  Occasionally, complement was added to decrease anti- 
complementary antigen. This was inactivated by zymosans rather than heat to 
preserve all the antigens. 
Gel Diflusion and Immunoelectrophoresis. Antigens for gel diffusion and im- 
munoelectrophoresis were grown in medium with rabbit serum. Organisms were 
washed three times in phosphate-buffered saline (0.15M, pH 7.4) and centrifuged 
at 17,300 X g for 30 minutes. The final pellet was suspended in distilled water 
representing a 200-fold concentration. Antigens were frozen and thawed five times. 
Gel diffusion was performed by a modification of the Ouchterlony technique.' 
A thin layer of 1 %  Ionagar in distilled water was dried on 3 %  X 4 inch glass 
plates at 80°C. Then an overlay of 12 ml of 1 % Ionagar in phosphate-buffered 
saline (pH 7.4) was allowed to spread evenly. The plates were placed at 4°C 
overnight before use. Six holes and a center well were cut in the agar with a 
Feinberg agar cutter. Antigen was usually placed in the center well, with rabbit 
antisera in the side wells. Plates were incubated for three days at 37°C in a 
humidified chamber, washed for 24 hours in normal saline, rinsed in distilled water 
and air-dried. Precipitin lines were drawn as they appeared and the dried plates 
were stained with Amidoschwarz s t a h a  
TABLE 2
COMPLEMENT-FIXATION ESTS 
ISOLATES FROM RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS 
Rabbit Antiserum Titers 
Antigen 
H-EM* A-MK' A-AJ t A-DMt 
H-EM 10,240$ 5120 1280 1280 
A-MK 2560 2560 2560 1280 
A-kl 5 120 5120 10,240 2560 
A-DM 5120 5120 5 120 5120 
Rheumatoid arthritis. 
t Systemic lupus erythematosus. 
$ Reciprocal titer. 
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TABLE 3 
COMPLEMENT-FIXATION ESTS 
RELATIONSHIP OF ISOLATED STRAINS TO OTHER STRAINS 
Rabbit Antiserum Titers 
M.hom.  M.hom.  M.sal. M.orale M.ferm.  M.pneu. GDL* H-EMt 
Antigen type1 type2 (FW 
M. hominis type 1 2,560t 
M .  salivariurn 
M .  orale 
M .  jermentans 160 
M .  pneumoniae (FH) 160 
GDL 320 
H-EMt 80 
* Strain of Butler and Leach. 
7 Rheumatoid arthritis. 
t Reciprocal titer. 










<20 40 80 320 160 80 
<20 40 80 160 160 40 
20,480 40 80 320 160 20 
160 20,480 40 320 160 80 
80 20 <: 5;: "i: 2,:; 80 320 
160 320 80 640 10,240 5,120 
320 20 160 320 5,120 5,120 
Microimmunoelectrophoresis was performed using techniques similar to those 
described by Campbell et al.O Microscope slides (1  X 3 inches) were covered 
with a thin layer of 1 % Ionagar in barbital buffer at pH 8.2. Two antigens were 
electrophoresed on each slide using similar buffer at a constant current of 5 MA 
for 90 minutes in a Shandon apparatus. Rabbit antisera was introduced into the 
center slit and the plates were incubated for 24 hours at room temperature in a 
humidified chamber. Precipitin lines were drawn as they appeared. The slides were 
washed, dried and stained as described above. 
When testing antigens for heat lability, aliquots were heated in a constant 
temperature water bath at 56' and 60'C for 30 minutes. Better separation of 
precipitin lines occurred when antigen rather than antibody was electrophoresed. 
On each slide, both a control untreated antigen and a treated antigen were electro- 
phoresed. 
Growth-inhibition Tests. The method as described by Clyde'O was also used for 
identification of the isolated strains. Zones of inhibition of growth around 6mm 
filter paper discs containing 0.025 ml of rabbit antisera were measured in milli- 
meters. 
TABLE 4 
ISOLATES FROM REITER'S YNDROME 
Rabbit Antiserum Titers 
COMPLEMENT-FIXATION TESTS 
M .  homlnis 
Antigen A-DS' type 1 A-DF* type 2 
M .  horninis 
~~ 
A-DS 5120t 320 40 160 
M. horninis 
type 1 1280 2560 40 80 
A-DF 320 80 2560 2560 
M. horninis 
type 2 40 4 0  320 1280 
Reiter's syndrome. 
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Results 
The two cloned strains from RA and two from SLE cross-reacted closely with 
each other by complement-fixation tests (TABLE 2) .  When compared to other 
characterized mycoplasma strains, the prototype strain H-EM reacted only with 
the GDL strain of Butler and Leach" (TABLE 3).  TABLE 4 shows that by com- 
plement-fixation tests, the two isolated strains from Reiter's syndrome cross- 
reacted with M .  hominis types 1 and 2, respectively. However, both strains reacted 
more strongly in one direction, indicating some antigenic difference. By the 
method of growth-inhibition (TABLE S),  the two Reiter's strains were similarly 
identified as M. hominis type 1 and type 2. However strains H-EM (prototype 
RA strain) and the GDL did not inhibit each other. 
By gel diffusion, the results agreed with the complement-fixation tests. An ex- 
ample in FIGURE 1 shows the lines of identity among several RA and SLE strains 
and the GDL strain. FIGURE 2 shows the line of identity between M. horninis type 
2 and A-DF from Reiter's syndrome. 
The other isolates tested from RA and SLE were identified by growth-inhibition 
using a polyvalent antiserum composed of equal amounts of antisera to cloned 
strains A-MK, H-EM, A-AJ, and A-DM. TABLE 6 shows that all of these isolates 
(both cloned and uncloned) are closely related. 
Control studies showed no precipitin lines between control rabbit antiserum 
and any of the gel diffusion antigens except for M .  pneumoniae. This strain would 
grow only in broth medium containing horse serum. A control antigen of broth 
did not react with any of the rabbit antisera. Complement-fixation tests using all 
strains and control rabbit antiserum were less than 1 :40 except for M. pneumoniue 
which reacted at 1:320. No growth-inhibition occurred to any strain with the 
control rabbit antiserum. 
FIGURE 1. Gel diffusion showing lines of identity among the rheumatoid arthritis-systemic 
lupus erythematosus strains and the GDL strain. PV-polyvalent antiserum. 
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FIGURE 2. Gel diffusion showing line of identity between M. hominb type 2 and isolate 
A-DF from Reiter's syndrome. 
TABLE 6 
GROWTH-INHIBXTION ESTS 
Isolates Polyvalent AIIthNm* 
A-DML 4.5t 
A-kl= 3 .O 
A-HNL 3.5 
A-DBL 3.5 








Antisera to strains A-AJ, A-DM, H-EM, and A-MK. 
t Zone of growth inhibition in millimeters. 
I. Systemic lupus erythematosus. 
Underlined isolates cloned twice. 
Rheumatoid arthritis. 
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TABLE 7 
COMPLEMENT-FIXATION TESTS 
Polyvalent Antigen Titer 
0 1:8-1:32 1:64-1:256 >1:256 Total 
Rheumatoid Arthritis. 5 22 23 2 50 
Controlst 48 2 0 0 50 
Def. or class. 
Fifteen synovial fluid and 35 sera. 
t Ten synovial fluids and 40 sera. 
Studies of Circulating Antibody. Earlier studies of complement-fixing antibody 
in patients with RA indicated that titers varied considerably with the different 
isolated strains. Minor antigenic differences among the RA-SLE strains were 
noted with gel diffusion and complement-fixation tests. Antibiotic sensitivity also 
varied among these strains especially to chloramphenicol and kanamycin. For 
these reasons, a polyvalent complement-fixing antigen was composed of equal 
amounts of cloned strains H-EM, A-MK, A-AJ, and A-DM, two each from SLE 
and RA. 
Serum and synovial fluid from patients with definite or classical RA were tested 
for complement-fixing antibody using the polyvalent antigen and M. horninis 
type 1 for comparison. An equal number of control specimens were studied. 
This group consisted of patients on general medical wards with unrelated diseases, 
but including serum and synovial fluid from gout and osteoarthritis patients. The 
other half of the control group were from university faculty members undergoing 
routine periodic health examinations. 
TABLE 7 shows the results of complement-fixation tests in patients with RA 
and the control group using the polyvalent antigen. 90% of the rheumatoid pa- 
tients were positive in titers of l : 8 or higher, and 46% were positive at l :64 or 
greater. Only 4% of the control specimens reacted; these were all in low titer. 
Complement-fixation titers to M. hominis type 1 are shown in TABLE 8. 26% 
of the RA specimens and 16% of the control group reacted, all in low titers of 
1:32 or less. Both groups were tested with a control antigen, and these were 
negative. 
During the study of complement-fixation testing for antibody in human speci- 
mens, it became apparent that the antigens were in part heat-labile at  56OC. 
TABLE 8 
COMPLEMENT-FIXATION TESTS 
M. hornlnls type 1 Titer 
0 1:8-1:32 1:64-1:256 >1:256 Total 
Rheumatoid Arthritis. 31 13 0 0 50 
Controlst 42 8 0 0 50 
Def. or class. 
Fifteen synovial fluid and 35 sera. 
t Ten synovial fluids and 40 sera. 
Bartholomew: Rheumatoid Arthritis 529 
TABLE 9 
EFFECT OF HEAT-TREATED ANTIGEN (56'C-30 MIN) 
UPON COMPLEMENT-FIXATION TITERS 
~~ 
~~ ~ 
Untreated Antigen Treated Antigen 
1:256 1:8 
1:256 1:32 
1 :256 1:32 
1:256 1:32 
1:128 1:32 
1 : 128 1:8 
1:128 1:8 
1 : 128 0 
1 : 128 0 






TABLE 9 shows the results of testing 15 specimens of synovial fluid and serum 
from patients with RA when the polyvalent antigen was heated at 56°C for 30 
minutes. In each case, antibody titer decreased, often to less than 1 :&the lowest 
dilution tested. Further studies of heat lability of mycoplasma antigens were 
undertaken using gel diffusion and immunoelectrophoresis. The latter method 
gave better definition of antigen-antibody reactions. 
FIGURE 3 shows that M. hominis type I antigen is quite heat stabile even at 
FIGURE 3. Immunoelectrophoresis of M. horninis, type 1 ,  showing no loss of precipitin lines 
at 56" and 60°C. 
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FIGURE 4. Immunoelectrophoresis of M. orale, type 1, showing partial loss of precipitin 
lines at 56" and complete loss at 6 O O C .  
FIGURE 5 .  Immunoelectrophoresis of strain H-EM from rheumatoid arthritis, showing loss 
of one precipitin line at 56"C, and complete loss at 60%. 
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FIGURE 6. Immunoelectrophoresk of strain A-DF from Reiter's syndrome showing no loss 
of precipitin lines at 56" or 60" C. 
TABLE 10 
IMMUNOELECTROPHO~IS 
EFFECT OF TEMPERATURE ON PRECPITIN L m s  
Number of Precipitin Lines 
50°C 5 5 o c  600C Strain Untreated Antigen 
M .  horninis 1 1 1 1 1 
M .  hominis 2 5 5 5 5 
M .  salivarium 4 1 1 1 
M. orale 2 1 1 0 
GDL 3 2 1 0 
A-JH' 4 4 3 1 
H-EM* 2 2 1 0 
Rheumatoid arthritis. 
6OOC. Mycoplasma orale type 1 (FIGURE 4) shows partial loss of antigen at  56' 
and complete loss at 60°C. Strain H-EM (RA strain) shows loss of one precipitin 
line at 56" and both at 60°C (FIGURE 5 ) .  Strain A-DF (related to M. horninis 
type 2) is stabile at  these temperatures, (FIGURE 6 ) .  TABLE 10 summarizes the r e  
sults in the strains tested. Mycoplasrna horninis types 1 and 2 showed no loss of 
precipitin lines with heating up to 6OOC. The other strains tested all showed loss 
of precipitin lines including the GDL and two RA strains. 
When the heat-treated complement-fixing antigen was tested against specific 
rabbit antisera, very little loss in titer occurred, except for strain H-EM where 
a three tube decrease was noted (TABLE 1 1 ) . 
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TABLE 11
&FECT OF TEMPEBAIURB UPON COMPLEMENT-FIXATION TITER 
Rabbit Antiacnrm Complement-Rxation Titer 
AntigEn Untreated S6OC 60% 
M. hominis 1 1 : 1280 1 : 1280 1 : 1280 
M. hominis 2 13x0 1:640 1:640 
M. salivarium 1 : 1280 1:640 1:640 
M. orale 1 :2560 1:1280 1 : 1280 
GDL 1:5120 15120 1:5120 
A-JH. 1 :2560 1:2560 1 : 1280 
€I-EM* 1:20480 15120 1 :2560 
Rheumatoid arthritis. 
Discussion 
The mycoplasma strains isolated from patients with RA and SLE are closely 
related to each other antigenically, and are of the same type first reported by 
Butler and Leach.” This was discovered in a H E p 2  continuous cell line. The 
origin of this strain is unknown. Girardi et a1.2 have reported its isolation in 
several primary cell lines, including chick embryo and green monkey kidney. 
The only direct isolation of this strain is by Hayfli~k.’~ who reported isolation 
in a human bladder tumor. This strain has also been found in other cell cultures 
inoculated with material from solid tumor and 1e~kemia.I~ As yet, there is no 
evidence that it is an animal strain. It is conceivable that this strain is of human 
origin, which usually requires cell culture passage before it will grow in cell-free 
medium. / 
Despite the fact that all control cell culture tubes and those inoculated with 
specimens from other “control diseases” remained free of mycoplasma, the pos- 
sibility of contaminating mycoplasma exists. 
However, the results of complement-fixation tests suggest that there is circulat- 
ing antibody against these strains in cases of established RA. A nonspecific effect 
of rheumatoid sera or synovial fluid is unlikely, as the results using M. hominis 
type 1 antigen were quite different and agreed with the control series. There was 
no correlation between the complement-king titer and the presence of rheuma- 
toid factor as measured by the latex fixation test. Patients with very early RA or 
those in complete remission had negative complement-fixation tests. 
These preliminary studies indicate that certain antigens of mycoplasma are 
heat-labile. Such antigens have been described in certain viral species as psitta- 
cosis,I5 influenza,16 and foot-and-mouth disease.” Further study of these 
characteristics is indicated, as it may affect the results of serologic testing. 
The fact that rabbit antisera titers drop very little with the heated antigen indi- 
cates that, in this host, antibody is probably directed against all antigens includ- 
ing those which are heat-stabile. As rabbits do  not develop overt disease to these 
strains, a direct correlation to antibody formed as a result of actual infection can 
not be made. 
Initial studies of growth-inhibiting antibody in RA sera against these strains 
using metabolic inhibition methods have been negative. 
The results of typing the two isolates from Reiter’s syndrome are inconclusive. 
Mycoplasma hominis type 1 is the most common tissue culture contaminant. 
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Mycoplasma hominis type 2 has been identified in humPn material from the 
genitourinary tract, but there is evidence that it is related to M. arihritidis in rats.18 
It has not been a common cell culture ~0ntaminant. l~ It is unlikely that rat con- 
tamination occurred, as there was no contact with them at the time this isolate was 
discovered. Furthermore, this strain (A-DF) has been inoculated into 20 young 
white rats intrapexitoneally and no disease occurred, nor could the strain be re- 
isolated from the animals after 24 hours. Study of circulating antibody of this 
strain are in progress. 
Summary and Conclusions 
Mycoplasma strains from synovial fluid, serum, bone marrow aspirate, and 
kidney tissue of patients with RA and SLE have been antigenically characterized 
as related to, the GDL strain of Butler and Leach. Two strains from synovial fluid 
of Reiter’s syndrome are strains of M. hominis types 1 and 2. 
Complement-fixing antibody has been demonstrated in 90% of patients with 
established RA against these strains isolated. The antigen responsible for this 
response appears to be heat-labile at 56°C. Heat-labile antigens occur in several 
human mycoplasma strains, as well as the GDL strain. 
The GDL strain has now been identified by several laboratories as M. 
hyorhinis - isolated from swine and causing arthritis and polyserositis. 
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